Combined treatment with ATO and THAL can inhibit proliferation and invasion of AML cells by down-regulatingULK1 and BECLIN1 and up-regulating PTEN and IL6, and this effect was more marked than the effects of ATO and THAL alone. Here, BECN1 is linked to acute myeloid leukemia.